Why Some Hedge Funds Aren’t Smarting Over JUUL’s Woes

Last year’s Altria deal may have saved the investments of hedge funds and others who earlier poured money into the embattled e-cigarette maker.

(David Paul Morris/Bloomberg)

(David Paul Morris/Bloomberg)

Another day, another round of bad news for JUUL.

The business model of the e-cigarette maker — and unofficially the third-most-valuable pre-IPO company — is under attack and its valuation is seemingly going up in smoke.

The controversial company is being blamed for the recent vaping deaths and the epidemic of teen vaping.

To continue reading, subscribe now to Premium Journalism. Already a subscriber? login.